Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084696

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084696

MedTech & Biopharma Device CMO/CDMO Market, By Product/Device Type, By Service Type, By Device Class, By Geography

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

MedTech & Biopharma Device CMO/CDMO Market is estimated to be valued at USD 110,227.2 Mn in 2026 and is expected to reach USD 271,758.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 13.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 110,227.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 13.80% 2033 Value Projection: USD 271,758.5 Mn

The global MedTech & biopharma device CMO/CDMO market includes contract development and manufacturing services for medical devices, diagnostics, drug-device combination products, and drug delivery devices with high growth and innovation, as well as contract development and manufacturing services for devices and medical and healthcare applications. By functioning as outsourcing partners, CMOs/CDMOs help client companies design, engineer, provide and integrate regulatory, manufacturing, packaging and logistics.

The need to control operational and product development expenses, speed product to market, gain market access for new innovative products and leverage specialized know how is encouraging pharmaceutical, medical device, and biopharmaceutical industries to seek an outsourced product design, development and manufacturing partner solution. Increased usage of autoinjector devices and biologics delivery devices, wearable medicals devices, and associated healthcare devices will require partnerships with strategically positioned CMOs/CDMOs throughout the life science industry, including drug development and delivery device and drug device combinations.

Market Dynamics

The global MedTech & biopharma device CMO/CDMO market is driven by the rising level of outsourcing of device development and manufacturing functions. Adoption of drug device combination products, biologics delivery devices and connected devices for medtech devices is promoting life sciences players to attain CMO/CDMO competency to optimize time-to-market, manufacturing and cost efficiency.

However, a number of constraints are present in the market, such as stringent regulatory barriers, tedious validation process, and high-quality protection cost. These market limitations coupled with the bottlenecks in the supply chain and the limited capacity for niche manufacturing services pose hurdles to the market advancement. Nevertheless, increasing adoption of innovative drug delivery devices and wearable healthcare technologies as well as shift toward strategic outsourcing by emerging life sciences organizations will offer new opportunities for growth in MedTech & biopharma device CMO/CDMO market.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global MedTech & biopharma device CMO/CDMO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Integer Holdings Corporation, Jabil Inc., Flex Ltd., Sanmina Corporation, Phillips-Medisize, Nordson MEDICAL, West Pharmaceutical Services, Gerresheimer AG, SteriPack Group, and Nipro Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global MedTech & biopharma device CMO/CDMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global MedTech & biopharma device CMO/CDMO market

Market Segmentation

  • Product/Device Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Drug-Device Combination Products
  • Medical Devices
  • Diagnostics and Laboratory Devices/Equipment
  • Other Product / Device Types
  • Service Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Design Development and Engineering Services
  • Contract manufacturing
  • Supply Chain Management
  • Quality and Regulations
  • Other Value-Added Services
  • Device Class Insights (Revenue, USD Mn, 2021 - 2033)
  • Class I
  • Class II
  • Class III
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Integer Holdings Corporation
  • Jabil Inc.
  • Flex Ltd.
  • Sanmina Corporation
  • Phillips-Medisize
  • Nordson MEDICAL
  • West Pharmaceutical Services
  • Gerresheimer AG
  • SteriPack Group
  • Nipro Corporation
Product Code: CMI9692

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global MedTech & Biopharma Device CMO/CDMO Market, By Product/Device Type
    • Global MedTech & Biopharma Device CMO/CDMO Market, By Service Type
    • Global MedTech & Biopharma Device CMO/CDMO Market, By Device Class
    • Global MedTech & Biopharma Device CMO/CDMO Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Industry Trends

4. Global MedTech & Biopharma Device CMO/CDMO Market, By Product/Device Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Drug-Device Combination Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Medical Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Diagnostics and Laboratory Devices/Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Other Product / Device Types
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global MedTech & Biopharma Device CMO/CDMO Market, By Service Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Design Development and Engineering Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Contract manufacturing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Supply Chain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Quality and Regulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Other Value-Added Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global MedTech & Biopharma Device CMO/CDMO Market, By Device Class, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Class I
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Class II
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Class III
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global MedTech & Biopharma Device CMO/CDMO Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product/Device Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Device Class, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Integer Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jabil Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Flex Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanmina Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Phillips-Medisize
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nordson MEDICAL
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • West Pharmaceutical Services
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Gerresheimer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SteriPack Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nipro Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!